Completed
A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis
NCT01789242
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +2 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford Cancer Institute Stanford, California, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Boston University Medical Center Boston, Massachusetts, United States